Nublexa contains the active substance regorafenib.
It is a medicine used to treat cancer by slowing down the growth and spread of cancer cells and cutting off the blood supply that keeps cancer cells growing.
Nublexa is a multikinase inhibitor (MKI) that targets cancer growth and progression by inhibiting multiple protein kinase.
Treatment with Nublexa has shown to improve survival in patients with colorectal cancer and advanced gastrointestinal stromal tumour (GIST) who have been previously treated with 2 tyrosine kinase inhibitors.
Warning & Precautions